Big movements in Oncology Pharma Inc. stock price on Tuesday moving 10.33% between high and lowStockInvest.us, 1 month ago
The Oncology Pharma Inc. stock price fell by -3.87% on the last day (Tuesday, 24th Aug 2021) from $15.00 to $14.42. and has now fallen 7 days in a row. During the day the stock fluctuated 10.33% from a day low at $13.55 to a day high of $14.95. The price has fallen in 7 of the last 10 days and is down by -26.43% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -86 thousand shares and in total, 168 thousand shares were bought and sold for approximately $2.42 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.Given the current short-term trend, the stock is expected to fall -25.95% during the next 3 months and, with a 90% probability hold a price between $7.77 and $21.18 at the end of this 3-month period.
There are few to no technical positive signals at the moment. The Oncology Pharma Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $17.41 and $22.21. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 15, 2021, and so far it has fallen -60.38%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.40 between high and low, or 10.33%. For the last week, the stock has had a daily average volatility of 16.23%.
Oncology Pharma Inc. is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Oncology Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.Check full Oncology Pharma Inc. forecast and analysis here.